These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 31481953)

  • 1. Immune Response to Mucosal
    López-Santiago R; Sánchez-Argáez AB; De Alba-Núñez LG; Baltierra-Uribe SL; Moreno-Lafont MC
    Front Immunol; 2019; 10():1759. PubMed ID: 31481953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and immune response in Brucella infection acquired by the respiratory route.
    Ferrero MC; Alonso Paiva IM; Muñoz González F; Baldi PC
    Microbes Infect; 2020 Oct; 22(9):407-415. PubMed ID: 32535086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in
    Yang X; Skyberg JA; Cao L; Clapp B; Thornburg T; Pascual DW
    Front Biol (Beijing); 2013 Feb; 8(1):60-77. PubMed ID: 23730309
    [No Abstract]   [Full Text] [Related]  

  • 4. Important biology events and pathways in Brucella infection and implications for novel antibiotic drug targets.
    Gao G; Xu J
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):65-76. PubMed ID: 23557338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brucella spp. Virulence Factors and Immunity.
    Byndloss MX; Tsolis RM
    Annu Rev Anim Biosci; 2016; 4():111-27. PubMed ID: 26734887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by
    Muñoz González F; Sycz G; Alonso Paiva IM; Linke D; Zorreguieta A; Baldi PC; Ferrero MC
    Front Immunol; 2019; 10():1775. PubMed ID: 31402921
    [No Abstract]   [Full Text] [Related]  

  • 7. Establishment of Chronic Infection: Brucella's Stealth Strategy.
    Ahmed W; Zheng K; Liu ZF
    Front Cell Infect Microbiol; 2016; 6():30. PubMed ID: 27014640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment.
    Fugier E; Pappas G; Gorvel JP
    Expert Rev Mol Med; 2007 Dec; 9(35):1-10. PubMed ID: 18088444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The innate immune response against Brucella in humans.
    Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP
    Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evasion of anti-infectious immunity by Brucella - A review].
    Quan W; Yang Y
    Wei Sheng Wu Xue Bao; 2016 May; 56(5):747-52. PubMed ID: 29727136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic and protective antigens of Brucella as vaccine candidates.
    Masjedian Jezi F; Razavi S; Mirnejad R; Zamani K
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():29-36. PubMed ID: 31300122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune encounters of the (Type) 4th kind: Brucella.
    de Jong MF; Rolán HG; Tsolis RM
    Cell Microbiol; 2010 Sep; 12(9):1195-202. PubMed ID: 20670294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory animal models for brucellosis research.
    Silva TM; Costa EA; Paixão TA; Tsolis RM; Santos RL
    J Biomed Biotechnol; 2011; 2011():518323. PubMed ID: 21403904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brucella virulence mechanisms and implications in novel vaccines and drugs.
    Gao G; Wang Y; Chen Z; Xu X; Xu J
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):49-64. PubMed ID: 23557337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development.
    Cannella AP; Tsolis RM; Liang L; Felgner PL; Saito M; Sette A; Gotuzzo E; Vinetz JM
    Front Cell Infect Microbiol; 2012; 2():1. PubMed ID: 22919593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the immunopathogenesis of Brucellosis.
    Amjadi O; Rafiei A; Mardani M; Zafari P; Zarifian A
    Infect Dis (Lond); 2019 May; 51(5):321-333. PubMed ID: 30773082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen.
    Avila-Calderón ED; Flores-Romo L; Sharon W; Donis-Maturano L; Becerril-García MA; Arreola MGA; Reynoso BA; Güemes FS; Contreras-Rodríguez A
    Folia Microbiol (Praha); 2020 Feb; 65(1):1-16. PubMed ID: 30783994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal affairs: investigating the Brucella intracellular lifestyle.
    von Bargen K; Gorvel JP; Salcedo SP
    FEMS Microbiol Rev; 2012 May; 36(3):533-62. PubMed ID: 22373010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.